EDGE
Get a demo
Log In
All Updates

All Updates

icon
Filter
Last week:
Funding
Mirador Therapeutics raised USD 400 million in seed funding to develop therapeutics targeting immune-mediated inflammatory and fibrotic conditions
Precision Medicine
Mar 21, 2024
Funding
Clasp Therapeutics raises USD 150 million in Series A funding to conduct clinical trials of therapeutic candidates
Precision Medicine
Mar 20, 2024
M&A
AstraZeneca to acquire Fusion Pharmaceuticals for ~USD 2.4 billion to advance cancer treatment capabilities
Precision Medicine
Mar 19, 2024
Funding
Proscia raises USD 46 million in Series C funding to develop AI-enabled applications
Precision Medicine
Mar 13, 2024
Funding
Zephyr AI raises USD 111 million in Series A funding to accelerate data analyzing
Precision Medicine
Mar 13, 2024
Partnerships
IDEAYA Biosciences and Merck partner to evaluate IDE161 with KEYTRUDA in endometrial cancer trial
Precision Medicine
Mar 12, 2024
Partnerships
ArteraAI partners with Movember to develop personalized cancer treatment targeting prostate cancer
Precision Medicine
Mar 12, 2024
Funding
Ventyx Biosciences secures USD 100 million private placement to support clinical and preclinical development of therapeutic candidates
Precision Medicine
Mar 7, 2024
Funding
Alumis raises USD 259 million in upsized Series C funding to support clinical trials of lead drug candidate 'ESK-001'
Precision Medicine
Mar 5, 2024
Funding
FogPharma raises USD 145 million in Series E funding to support anti-cancer compound 'FOG-001' clinical development
Precision Medicine
Mar 1, 2024
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.